Hydroxyamine

Hydroxyamine

SCHEMBL1758437

Cl.NO.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydroxyamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyamine SCHEMBL28915675 1.00
Hydrazine SCHEMBL27794370 0.91
Hydroxyamine SCHEMBL18614724 0.89
Hydroxyamine SCHEMBL351722 0.89
Hydroxyamine SCHEMBL30786426 0.89
Hydroxyamine SCHEMBL1129 0.89
Hydroxyamine SCHEMBL482304 0.89
Hydroxyamine SCHEMBL1331311 0.89
Hydroxyamine SCHEMBL10610314 0.89
Hydroxyamine SCHEMBL3590179 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111484644-A Method for preparing, separating and enriching uranium from polyamidoxime/graphene nanoribbon composite aerogel 东华理工大学 2020-08-04 CN claimed
CN-117549390-A Oxime amine cellulose nanofiber filled nanometer wood and preparation method thereof 中国科学院青岛生物能源与过程研究所 2024-02-13 CN disclosed
CN-116749567-A Ultralight insole preparation equipment and process 泉州源利鞋材有限公司 2023-09-15 CN disclosed
CN-107771180-B TGR5 modulators and methods of use thereof 英特塞普特医药品公司 2021-03-23 CN disclosed
CN-111484644-A Method for preparing, separating and enriching uranium from polyamidoxime/graphene nanoribbon composite aerogel 东华理工大学 2020-08-04 CN disclosed
US-9487538-B2 Two-carbon linked artemisinin-derived trioxane dimers THE JOHNS HOPKINS UNIVERSITY (US) 2016-11-08 US disclosed
US-20150361088-A1 TWO-CARBON LINKED ARTEMISININ-DERIVED TRIOXANE DIMERS THE JOHNS HOPKINS UNIVERSITY (US) 2015-12-17 US disclosed
EP-2496551-B1 A FACILE SYNTHESIS OF 3-AMINOPICRIC ACID PACIFIC SCIENT ENERGETIC MATERIALS CO (US) 2014-03-05 EP disclosed
US-8404897-B2 Facile synthesis of 3-aminopicric acid PACIFIC SCIENTIFIC ENERGETIC MATERIALS COMPANY (US) 2013-03-26 US disclosed
EP-2496551-A1 A FACILE SYNTHESIS OF 3-AMINOPICRIC ACID Pacific Scientific Energetic Materials Company (US) 2012-09-12 EP disclosed
EP-1677783-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE Nicholas Piramal India Limited (IN) 2006-07-12 EP disclosed
WO-2005035495-A2 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE NICHOLAS PIRAMAL INDIA LIMITED (IN) 2005-04-21 WO disclosed
CN-1168721-C 5-cyano-2-aminopyrimidine derivatives О 2004-09-29 CN disclosed
CN-1419541-A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors APPLIED RES SYSTEMS AKS HOLDIN (NL) 2003-05-21 CN disclosed
CN-1370152-A 5-cyano-2-aminopyrimidine derivatives CELLETECH CHIROSCIENCE LTD (GB) 2002-09-18 CN disclosed
WO-1999032445-A1 OXIMINO-PIPERIDINE, -PYRROLIDINE AND -AZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MUSCARINIC RECEPTOR (ANT-)AGONISTS ALCON LABORATORIES, INC. (US) 1999-07-01 WO disclosed
US-5336789-A Also insecticides, miticides, nematocides AMERICAN CYANAMID COMPANY (US) 1994-08-09 US disclosed
EP-0238258-B1 Macrolide compounds AMERICAN CYANAMID CO (US) 1994-01-26 EP disclosed
US-5185456-A Insecticides, nematocids, miticides; antibiotics AMERICAN CYANAMID COMPANY (US) 1993-02-09 US disclosed
EP-0238258-A1 Macrolide compounds AMERICAN CYANAMID COMPANY (US) 1987-09-23 EP disclosed